patients undergoing abdominoplasty surgery Abdominoplasty,
Conditions
Interventions
58 patients,
undergoing elective abdominoplasty,
received general anesthesia. Patients were randomly assigned to two equal groups of 29 patients each. Preoperatively,
the patients were educated to the use of the spirometry and visual analog scale (VAS) to monitor their pain postoperatively (where 0 represented no pain,
and 10 meant the worst possible pain). In arm 1 the non-
blocked group on arrival at the operating theatre,
the patients were monitored by electrocardiography,
non‑invasive blood pressure,
and pulse oximetry. Intravenous infusion of warm ringer’s lactate solution was initiated. All patients received general anesthesia
midazolam 0.03 to 0.05 mg/kg was given intravenously. After adequate pre-
oxygenation,
anesthesia was induced by IV fentanyl 1 to 2 μg/kg,
propofol 1.5 to 2mg/kg,
and cisatracurium 0.15 to 0.2 mg/kg. Tracheal intubation was done and ventilator settings were adjusted to maintain the end‑tidal carbon dioxide tension at 30 to 35 mm Hg.
Anesthesia was maintained
oxygen–nitrous oxide mixture,
and IV cisatracurium incremental doses. Incremental doses of morphine 0.01 to 0.03 mg/kg were given intraoperatively with an interval of 30 min between each dose. After finishing,
isoflurane was discontinued,
Neuromuscular blockade was antagonized with 0.025 to 0.05 mg/kg neostigmine and 0.01 to 0.02 mg/kg atropine,
and then extubation was done for all patients. In PACU patient'
s ECG,
Sponsors
Al Kindi Specialised Hospital, Bahrain
Hospital Medical Director
Eligibility
Sex/Gender
All
Age
21 Years to 62 Years
Inclusion criteria
Inclusion criteria: patients undergoing elective abdominoplasty surgery with rectus sheath plication and ASA (I-II) patients.
Exclusion criteria
Exclusion criteria: patient’s refusal, patients with a history of known hypersensitivity to local anesthesia and psychiatric disorders, or use of psychiatric medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative pain postoperative patient admission period degree of pain | — |
Secondary
| Measure | Time frame |
|---|---|
| opioids consumption postoperative patient admission period drug dose | — |
Countries
Bahrain
Contacts
Public ContactHaytham Mohamed
Al Kindi Specialised Hospital, Bahrain
Outcome results
None listed